| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Cantourage Group SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €4.62 |
| 52 Week High | €11.40 |
| 52 Week Low | €4.56 |
| Beta | 0 |
| 11 Month Change | -31.04% |
| 3 Month Change | -34.93% |
| 1 Year Change | -52.81% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -76.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| HIGH | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -2.9% | 0.6% | 1.5% |
| 1Y | -52.8% | -14.5% | 5.9% |
Return vs Industry: HIGH underperformed the German Pharmaceuticals industry which returned -14.5% over the past year.
Return vs Market: HIGH underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| HIGH volatility | |
|---|---|
| HIGH Average Weekly Movement | 10.8% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: HIGH's share price has been volatile over the past 3 months.
Volatility Over Time: HIGH's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 625 | Philip Schetter | www.cantourage.com |
Cantourage Group SE operates as a medical cannabis company in Europe. It offers dried flowers, extracts, dronabinol products, and pharma-grade cannabidiol products. The company was founded in 2019 and is based in Kleinmachnow, Germany.
Cantourage Group SE Fundamentals Summary
| HIGH fundamental statistics | |
|---|---|
| Market cap | €62.97m |
| Earnings (TTM) | €38.68k |
| Revenue (TTM) | €1.66m |
1,628x
P/E Ratio37.9x
P/S RatioIs HIGH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HIGH income statement (TTM) | |
|---|---|
| Revenue | €1.66m |
| Cost of Revenue | €0 |
| Gross Profit | €1.66m |
| Other Expenses | €1.62m |
| Earnings | €38.68k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0031 |
| Gross Margin | 100.00% |
| Net Profit Margin | 2.33% |
| Debt/Equity Ratio | 0.0001% |
How did HIGH perform over the long term?
See historical performance and comparison